UPLOAD Filing
GridAI Technologies Corp.
Date: June 5, 2025 · CIK: 0001604191 · Accession: 0000000000-25-005939
AI Filing Summary & Sentiment
Reasoning
Letter
Re: Entero Therapeutics, Inc. Preliminary Proxy Statement on Schedule 14A Filed May 16, 2025 Dear Richard Paolone:
June 5, 2025
Richard Paolone Interim Chief Executive Officer Entero Therapeutics, Inc. 777 Yamato Road, Suite 502 Boca Raton, FL 33431
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
cc: Ross Carmel, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> June 5, 2025 Richard Paolone Interim Chief Executive Officer Entero Therapeutics, Inc. 777 Yamato Road, Suite 502 Boca Raton, FL 33431 Re: Entero Therapeutics, Inc. Preliminary Proxy Statement on Schedule 14A Filed May 16, 2025 Dear Richard Paolone: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Ross Carmel, Esq. </TEXT> </DOCUMENT>